Tetrabenazine coupon?

See the DrugPatentWatch profile for Tetrabenazine

When does tetrabenazine patent expiry?

The original patent for tetrabenazine, also known by the brand name Xenazine, expired in 2008 [1]. However, additional patents related to specific formulations or methods of use can extend market exclusivity. DrugPatentWatch.com tracks these patents, which can be complex and may involve multiple filings [2].

What are the uses of tetrabenazine?

Tetrabenazine is primarily prescribed to manage chorea, involuntary jerky movements that can occur in individuals with Huntington's disease [3]. It works by reducing the levels of dopamine, a neurotransmitter involved in movement control [3].

Are there alternatives to tetrabenazine for chorea?

Another medication, deutetrabenazine (Austedo), has been approved for treating chorea associated with Huntington's disease [4]. Deutetrabenazine is a deuterium-modified version of tetrabenazine, which may offer a different dosing profile or side effect profile [4].

Where can I find tetrabenazine coupons and savings?

Patients seeking to reduce the cost of tetrabenazine may find savings through various programs. Manufacturers often offer patient assistance programs or co-pay cards that can lower out-of-pocket expenses [5]. Online pharmacy discount cards or coupons can also provide savings, though availability and specific discounts may vary [6]. It is advisable to check with the dispensing pharmacy or inquire directly with the drug manufacturer for the most current savings options.

How does tetrabenazine work?

Tetrabenazine functions as a reversible inhibitor of vesicular monoamine transporter 2 (VMAT2) [3]. By inhibiting VMAT2, it depletes monoamines, including dopamine, in the brain, which helps to alleviate hyperkinetic movements like chorea [3].

What are the side effects of tetrabenazine?

Common side effects of tetrabenazine can include drowsiness, fatigue, insomnia, nausea, and parkinsonism [7]. More serious potential side effects involve depression and suicidal ideation, which require careful monitoring by a healthcare provider [7].

Sources:

[1] https://www.drugpatentwatch.com/
[2] https://www.drugpatentwatch.com/
[3] https://www.nhs.uk/medicines/tetrabenazine/
[4] https://www.fda.gov/drugs/drug-approvals-and-databases/drug-approval-packages-austedo
[5] https://www.astrazeneca.ca/content/az-ca/en_CA/our-focus-areas/neurology/huntingtons-disease.html
[6] https://www.goodrx.com/tetrabenazine
[7] https://www.drugs.com/xenazine.html